You have 9 free searches left this month | for more free features.

Anti-mitotic

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Apatinib Mesylate
  • Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Mar 1, 2023

Lymphoma, Large B-Cell, Diffuse Trial in Austria, Germany (Glofitamab, Rituximab, Obinutuzumab)

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Linz, Austria
  • +17 more
Mar 22, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Study of Mast Cell Precursors

Completed
  • Mastocytosis
  • Healthy Volunteer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 4, 2022

    Breast Cancer Trial in Istanbul (Soluble immune checkpoints)

    Recruiting
    • Breast Cancer
    • Soluble immune checkpoints
    • Istanbul, Turkey
    • +1 more
    Jul 14, 2022

    Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

    Recruiting
    • Gastrointestinal Stromal Tumors
    • Imatinib Mesylate
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Dec 22, 2022

    Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

    Recruiting
    • Lymphoma
    • +3 more
    • obinutuzumab
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))

    Terminated
    • Brain Metastases
    • Small Cell Lung Cancer
    • NovoTTF-200A
    • Stereotactic Radiosurgery (SRS)
    • Birmingham, Alabama
      University of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
    Feb 17, 2022

    Standard Anti-microtubule Drugs as Assessed by Early Tumor

    Recruiting
    • Breast Cancer
    • Breast Neoplasms
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Dec 10, 2021

    Diabetic Neuropathies Trial in Bani Suwayf (Carnosine)

    Completed
    • Diabetic Neuropathies
    • Carnosine
    • Banī Suwayf, Bani Suwayf, Egypt
      Beni Suef University faculty of pharmacy
    Jun 24, 2022

    SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Mesothelioma Trial in Cardiff (Vinorelbine, Active Symptom Control)

    Completed
    • Mesothelioma
    • Cardiff, United Kingdom
      Wales Cancer Trials Unit
    Oct 4, 2021

    NSCLC Trial in United States (NovoTTF-200T)

    Recruiting
    • Non-small Cell Lung Cancer
    • NovoTTF-200T
    • Birmingham, Alabama
    • +21 more
    Aug 15, 2022

    Glioblastoma, Adult Trial in Hackensack (device, drug, radiation)

    Active, not recruiting
    • Glioblastoma, Adult
    • NovoTTF-200A
    • +2 more
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Oct 7, 2021

    Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Angers, France
    • +24 more
    Mar 8, 2022

    Sarcoma Trial in Helsinki (Imatinib)

    Recruiting
    • Sarcoma
    • Helsinki, Finland
      Helsinki University Central Hospital
    Sep 26, 2022

    NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Aberdeen, United Kingdom
    • +24 more
    Nov 2, 2021

    Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

    Not yet recruiting
    • Stage II Melanoma
    • Relatlimab and nivolumab fixed dose combination (FDC)
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Oct 26, 2022

    Gastro-Oesophageal Cancer Trial in Worldwide (Regorafenib, Nivolumab, Docetaxel)

    Recruiting
    • Gastro-Oesophageal Cancer
    • Scottsdale, Arizona
    • +74 more
    Jan 11, 2022

    Medical Oncology Trial in Netherlands, United States (BAY1217389, Paclitaxel)

    Completed
    • Medical Oncology
    • Santa Monica, California
    • +6 more
    Apr 3, 2020

    Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

    Recruiting
    • Solid Tumor
    • Atlanta, Georgia
    • +4 more
    Feb 8, 2022

    Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

    Completed
    • Recurrent Squamous Cell Lung Carcinoma
    • Stage IV Squamous Cell Lung Carcinoma AJCC V7
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 21, 2021

    Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

    Not yet recruiting
    • Neoplasms
    • +7 more
    • Biological G207
    • Birmingham, Alabama
      Children's of Alabama
    Jun 1, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Suspended
    • Anatomic Stage III Breast Cancer AJCC v8
    • +12 more
    • Copanlisib Hydrochloride
    • Eribulin Mesylate
    • Gainesville, Florida
    • +10 more
    Nov 16, 2022

    Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)

    Active, not recruiting
    • Nonsmall Cell Lung Cancer
    • NSCLC
    • NovoTTF-200T
    • Immune checkpoint inhibitors or docetaxel
    • Birmingham, Alabama
    • +123 more
    Oct 13, 2022